Incorporate the Given Market Name Growth Accelerated by Advancements in Drug Therapy

 

Gout Disease Treatment 

Gout disease is a form of inflammatory arthritis caused due to buildup of uric acid crystals in the joints, resulting in sudden attacks of painful arthritis. Treatments for gout aim to reduce inflammation, prevent attacks, and lower uric acid levels in the blood. Advancements in drug therapy for gout such as introduction of interleukin-1 inhibitors, uricosuric drugs, and xanthine oxidase inhibitors have accelerated the growth of gout disease treatment market. The global gout disease treatment market is estimated to be valued at US$ 3.01 Bn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Introduction of interleukin-1 inhibitors such as canakinumab and rilonacept for the management of gout attacks has boosted the growth of the gout disease treatment market. These drugs directly block interleukin-1, a pro-inflammatory cytokine involved in acute gout attacks, and help provide faster relief from intense gout flares compared to conventional treatments. Additionally, development of novel uricosuric drugs such as lesinurad in combination with xanthine oxidase inhibitors help lower serum uric acid levels more effectively for long-term management of chronic gout. Advancements in drug therapy have improved treatment outcomes and quality of life of gout patients, thereby driving increased adoption of gout disease therapeutics.
Segment Analysis

The global Gout Disease Treatment market is segmented into drug class and geography. By drug class, the market is further divided into Xanthine Oxidase Inhibitors, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Biosimilars, and others. Xanthine Oxidase Inhibitors dominates the market currently with a market share of over 35% due to its high efficacy in inhibiting uric acid production, the root cause of gout.

Key Takeaways

The global Gout Disease Treatment market is expected to witness high growth. Regional analysis North America accounts for the largest market share of over 45% due to increasing prevalence of gout and rising healthcare spending in the region. Europe and Asia Pacific regions are also growing at a significant rate due to rapid urbanization and changing lifestyle in countries like India and China.

Key players operating in the Gout Disease Treatment market are Kerry Group plc, Takasago International Corporation, Sensient Technologies Corporation, Symrise AG, Givaudan SA, Firmenich International SA, Frutarom Industries Ltd., Citromax Flavors, Inc., and International Flavors & Fragrances Inc. Kerry Group plc dominates the market with a market share of over 20% and is investing significantly in research and development of innovative products.

North America accounts for the largest market share of over 45% due to increasing prevalence of gout and rising healthcare spending in the region. Europe is the second largest market for gout disease treatment with a share of over 30% due to better reimbursement policies. Asia Pacific is expected to witness highest growth during the forecast period expanding at a CAGR of 11.5% with countries like China and India emerging as major markets. This is owing to rising disposable incomes, growing awareness about treatment, and improving healthcare infrastructure in emerging Asian countries.

Key players operating in the Gout Disease Treatment market share are Kerry Group plc, Takasago International Corporation, Sensient Technologies Corporation, Symrise AG, Givaudan SA, Firmenich International SA, Frutarom Industries Ltd., Citromax Flavors, Inc., and International Flavors & Fragrances Inc. Kerry Group plc is one of the market leaders with a market share of over 20% and focuses on enhancing their drug portfolio for gout through strategic collaborations and acquisitions. Takasago International Corporation, produces natural and nature-identical flavoring ingredients, is investing significantly in gout drug research and development.

 

 Get more insights on this topic https://www.newswirestats.com/gout-disease-treatment-market-industry-insights-trendsgout-disease-treatment-market-2023-2030/

Comments

Popular posts from this blog

Increasing aircrafts deliveries to fuel the growth of Aircraft Radome Market

The Global Cryocooler Market Growth Accelerated By Rising Demand From Aerospace And Military Industries

The Global Dutch Brick Market Growth Accelerated By Increase In Residential Construction